Abilify Maintena injection and Canakinumab Subcutaneous
Determining the interaction of Abilify Maintena injection and Canakinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify Maintena, Aristada, Abilify, Abilify Discmelt, Abilify MyCite, Aristada Initio
Synonyms: Abilify Maintena (injection), Abilify Maintena
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abilify Maintena injection-Canasa
- Abilify Maintena injection-Canasa Pac rectal
- Abilify Maintena injection-Canasa rectal
- Abilify Maintena injection-Cancidas
- Abilify Maintena injection-Candesartan
- Abilify Maintena injection-Candesartan and Hydrochlorothiazide
- Canakinumab Subcutaneous-Abilify MyCite
- Canakinumab Subcutaneous-Abiraterone
- Canakinumab Subcutaneous-Abiraterone acetate
- Canakinumab Subcutaneous-Abiraterone Acetate (Yonsa)
- Canakinumab Subcutaneous-Abiraterone Acetate (Zytiga)
- Canakinumab Subcutaneous-Ablavar